Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies

v3.3.1.900
Commitments and Contingencies
6 Months Ended
Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
Note 11 Commitments and Contingencies
 
Lease Commitments – In May 2014, the Company entered into a lease of approximately 27,000 square feet of office, laboratory and clean room space to be leased for seventy two months. The lease requires monthly payments of $28,939 adjusted annually by approximately 3% plus triple net expenses monthly of $34,381 adjusted annually. The Company also made a security deposit of $750,000 which is held by the landlord, of which $187,500 has been returned to the Company and the remaining balance will be returned gradually over the next several years.
 
As of December 31, 2015, the minimum rental commitment under the lease is as follows:
 
Year Ending June 30,
 
 
 
 
2016
 
 
180,628
 
2017
 
 
370,252
 
2018
 
 
381,360
 
2019
 
 
392,855
 
2020
 
 
335,747
 
 
 
$
1,660,842
 
 
In September 2014, the Company entered into an equipment lease for laboratory equipment to be leased for twenty-four months with a bargain purchase option at the end of the lease. The equipment lease has been recorded as a capital lease with monthly payments of $8,075 per month to be made.
 
As of December 31, 2015, minimum rental commitment under the lease is as follows:
 
Year Ending June 30,
 
 
 
 
2016
 
$
48,619
 
2017
 
 
24,223
 
Total rental commitments
 
 
72,842
 
Less: Interest payments
 
 
(2,316)
 
Total lease payable
 
 
70,526
 
Lease payable, current portion
 
 
70,526
 
Lease payable, less current portion
 
$
-
 
 
Legal Matters - From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. As of December 31, 2015, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholders, is an adverse party or has a material interest adverse to our interest.